Beam Therapeutics (BEAM)
NASDAQ:BEAM
US Market
Holding BEAM?
Track your performance easily

Beam Therapeutics (BEAM) Financial Statements

1,237 Followers

Beam Therapeutics Financial Overview

Beam Therapeutics's market cap is currently ―. The company's EPS TTM is $-1.803; its P/E ratio is -14.15; Beam Therapeutics is scheduled to report earnings on November 4, 2024, and the estimated EPS forecast is $-1.19. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue$ 11.77M$ 7.41M$ 316.19M$ 17.19M$ 20.12M
Gross Profit$ 11.77M$ 7.41M$ 316.19M$ 17.19M$ 20.12M
EBIT$ -91.01M$ -110.39M$ 144.16M$ -96.09M$ -82.78M
EBITDA$ -85.44M$ -104.95M$ 149.53M$ -90.90M$ -77.96M
Net Income Common Stockholders$ -91.05M$ -98.67M$ 142.80M$ -96.09M$ -82.78M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 1.01B$ 1.09B$ 435.89M$ 1.02B$ 1.07B
Total Assets$ 1.26B$ 1.36B$ 1.46B$ 1.29B$ 1.35B
Total Debt$ 165.24M$ 168.12M$ 172.69M$ 173.98M$ 177.13M
Net Debt$ -842.93M$ -926.43M$ -263.21M$ -841.48M$ -895.89M
Total Liabilities$ 407.17M$ 446.31M$ 478.38M$ 511.59M$ 542.24M
Stockholders Equity$ 833.70M$ 913.49M$ 981.33M$ 778.94M$ 811.64M
Cash Flow-
Free Cash Flow$ -84.97M$ -102.19M$ 131.48M$ -97.73M$ -100.85M
Operating Cash Flow$ -83.01M$ -99.75M$ 135.07M$ -89.78M$ -84.67M
Investing Cash Flow$ 87.49M$ -53.46M$ 98.10M$ -10.23M$ -41.48M
Financing Cash Flow$ 133.00K$ 2.90M$ 33.71M$ 36.78M$ 107.54M
Currency in USD

Beam Therapeutics Earnings and Revenue History

Beam Therapeutics Debt to Assets

Beam Therapeutics Cash Flow

Beam Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis